Latest filing published 29 Mar 2019 for Isofol Medical AB, €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Gunnar Rabbe: trading record in brief
All filings by Anders Gunnar Rabbe on record concern Isofol Medical AB. We count 5 filings; the first trade dates from 19 January 2018 and the latest from 26 March 2019.
The open-market record is one-sided, with 3 purchases worth €58k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2019, the count stands at 2 purchases and no sales.
A typical purchase (the median) is worth €12k.
The newest entry dates from 29 March 2019: an open-market purchase of €12k, in Isofol Medical AB. The median gap between a trade and its publication by Finansinspektionen is 3 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Anders Gunnar Rabbe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 88,150 shares@ SEK 1.477.0% of flowTeckningsoptionFI:csv-b556cf4fed1cd4bdbda8Canonical exit: 24 Jun 2019 (T+90)
- 88,150 shares@ SEK 0.884.2% of flowTeckningsoptionFI:csv-4f2b22dc5492ab2513cdCanonical exit: 24 Jun 2019 (T+90)
- 15,000 shares@ SEK 27.0021.7% of flowISIN SE0009581051FI:csv-2feea97c0fe13a268d00Canonical exit: 2 Dec 2018 (T+90)
- 34,159 shares@ SEK 17.0033.5% of flowISIN SE0009581051FI:csv-e5290b165df60e4e2c5f
- 34,160 shares@ SEK 17.0033.5% of flowISIN SE0009581051FI:csv-69b3575e297929f4a950
5 of 5 declarations